bosentan anhydrous has been researched along with Diastolic Heart Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammer, M; Ebner, CH; Eichinger, J; Grander, W; Herold, M; Koller, B; Pretsch, I; Schwaiger, J; Steringer-Mascherbauer, R; Ulmer, H; Weber, T | 1 |
1 trial(s) available for bosentan anhydrous and Diastolic Heart Failure
| Article | Year |
|---|---|
Pilot Study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial).
Topics: Aged; Bosentan; Endothelin Receptor Antagonists; Heart Failure, Diastolic; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pilot Projects; Sulfonamides | 2017 |